The recently cloned uncoupling proteins -2 and -3 (UCP2, UCP3) cDNAs encode for proteins with 57 ± 59% homology with brown adipose tissuen uncoupling protein (UCP1) that can function as uncouplers of phosphorylation. The presentations of this Session of the Symposium were largely based on mRNA measurements, with one study showing that protein concentrations are well predicted by changes in mRNA in human muscles. Overall the observations suggest more complexity than anticipated. These observations are for the moment hard to reconcile with a simple role for these proteins in energy dissipation. Just the marked differences in tissue distribution of the two novel UCPs suggest they have different functions. It is possible that the activity, rather than the concentrations of these proteins, is regulated. The investigation of this possibility will hopefully enlighten us on their physiological role.
Great excitement has been raised by the cloning of the cDNAs of two novel uncoupling proteins (UCPs) nearly two years ago, 1 ± 3 UCP2 and UCP3. Their deduced sequences have about 73% of homology and bear 57 ± 59% resemblance with the prototype protein, the brown adipose tissue uncoupling protein, now dubbed UCP1. This, and the demonstration of reduction in the transmembrane potential in the mitochondria of yeast overexpressing the protein have led to believe that the novel UCPs are bona ®de uncouplers, much as UCP1. The expectations were high. These proteins could play an important role in the pathogenesis of obesity by being a factor in the capacity of the body to dissipate calories. They could well explain the proton leak postulated by Brand's group (see Session 1 and Brand 4 for reviews), as well as, part of the thermogenic effect of thyroid hormone (see Freake 5 and Silva 6 for reviews) and the responses of adult humans to challenges such as cold, fasting and overeating. These possibilities were an impetus for an avalanche of investigations seeking con®rma-tion of these expectations. The vast majority of the studies have focused on the regulation of the corresponding mRNAs and have generated both intriguing and exciting information. The observations, however, have not as yet de®ned the physiological role of these proteins, nor have they ful®lled the expectations just mentioned. Findings such as tissue distribution, changes in the mRNA levels in a direction opposite to the expected, or lack of response to situations known to stimulate or reduce thermogenesis, have shown that the challenge ahead is greater than anticipated. Results of studies aimed at de®ning a physiological role, presented at this Symposium, March 10, 1999, were again largely based on measurements of mRNA distribution and responses to experimental perturbations of the energy balance.
UCP2 mRNA is ubiquitously expressed. Denis Richard presented work done in collaboration with Daniel Ricquier adding yet other sites of expression of UCP2. With an in situ hybridization approach, he demonstrated abundant expression in the brain of the mouse and the rat, with some differences between the two species. The expression included neurons and the choroid plexus, but glial expression was not excluded. Notable sites of expression were the medulla (area postrema including the dorsal nucleus of the vagus nerve), several hypothalamic nuclei including those expressing CRF (paraventricular nucleus) and NPY (except for arcuate nucleus). Levels of mRNA in all these areas were conspicuously ®xed with no effect of cold, glucose, food deprivation, or leptin among others. Only in mice infected with toxoplasma, the injection of LPS was associated with an increase in UCP2 mRNA levels. He also examined the gastrointestinal tract and found expression in most places but most notably in areas of high replication rate of the epithelium. In the context of previous reports of ubiquitous presence of UCP2 mRNA and unanticipated responses [see for example References 1,7 ± 10], the present results support the concept that UCP2 may have different, tissue-speci®c functions. The induction by fatty acids and thiazolidinediones, notably in adipose and muscle cells, 11, 12 suggest that in these tissues, at least, UCP2 may have a role in the oxidation of fatty acids (see below).
Thyroid hormone is present in all vertebrates but only in warm-blooded animals (birds and mammals) does it increase oxygen consumption. 5, 6 Stimulation of ATP consuming processes such as extruding sodium from cells, leaking of calcium by the sarcoplasmic reticulum and metabolic cycles (e.g. lipolysislipogenesis) could account for only 50% of the thermogenic effect of thyroid hormone. 6 From independent calculations, Brand and colleagues have proposed that proton leak through the inner mitochondrial membrane could account for about 75% of the increase in thermogenesis between hypothyroidism and euthyroidism and about 50% of the increase in the transition from hypothyroidism to hyperthyroidism. 13 The stimulation of UCP3 mRNA in rat skeletal muscle by thyroid hormone shown by Reitman and colleagues (Session 3, and Harper and Brand 13 and Gong et al 14 ) makes this protein a good candidate to explain part of the thermogenic effect of thyroid hormone. It is disturbing that there is little or no UCP3 mRNA in tissues like liver, heart and stomach, where thyroid hormone markedly stimulates respiration. In these tissues, the increase in respiration could be tentatively explained as resulting from the increase in the utilization of ATP ± that is the increase in oxygen consumption (QO 2 ) would be the consequence of the stimulation of cell activity by thyroid hormone, rather than these tissues being thermogenic targets for this hormone. Moreover, there remains the con¯ict with the observation that the thyroid hormone-dependent proton leak is seen, and has been largely studied, by Brand and colleagues in hepatocytes and their mitochondria, whereas these cells do not express UCP2 or UCP3. Another intriguing observation made by Reitman's group is that UCP3 is increased in fasting and reduced by overfeeding. Interestingly, his mouse model of lipoatrophic diabetes that lacks white adipose tissue and fails, therefore, to increase fatty acids levels in response to fasting, does not exhibit an increase of UCP3 mRNA when fasted. An inclusive hypothesis is that at least part of the stimulation by thyroid hormone of the expression of this gene is indirect, mediated by the enhancement of the lipolytic responses by T 3 . Consistent with this hypothesis is the observation that b 3 -adrenergic receptor agonists increase UCP3 mRNA in wild type mouse, where it also increases fatty acids and resting energy expenditure (REE), but not in the lipoatrophic mouse model, where they fail to elevate fatty acids and REE.
Giacobino attempted to present a unifying hypothesis by his group regarding the thermogenic potential of UCP3. The basis for his argument included the results of overexpressing UCP3 in mammalian C2C12 myoblasts and a series of observations on UCP mRNA levels in various types of skeletal muscle and brown adipose tissue (BAT). Using a¯uorescent dye, his group has shown that the transfection of the cDNA in these myoblasts has an effect on mitochondrial transmembrane potential qualitatively similar to that of chemical uncouplers. His ®ndings in conditions expected to change intracellular fatty acid concentrations are consistent with these being an important signal for the expression of UCP3. In this regard, he explains the depression of UCP3 in BAT of fasted rats by reduced lipolysis secondary to the shutting down of sympathetic activity in this tissue, coupled to an inability of BAT to take up fatty acids from circulation, in spite of its elevation in fasted animals. He contended that some types of muscle, in contrast, take fatty acids avidly from circulation during fasting and thus undergo an increase in UCP3 mRNA. Consistent with the hypothesis of circulating fatty acids being an important signal for the expression of UCP3, his group has found a remarkably close correlation between plasma fatty acids and muscle UCP3 mRNA levels in humans.
Langin also presented results based on mRNA analysis, but using a sensitive RT-PCR assay. Most ®ndings agreed with those presented by Giacobino. Interestingly, Langin reported that while fasting is associated with an elevation of both UCP2 and UCP3 mRNA levels, food restriction is associated with a reduction. Correlations between resting energy expenditure and levels of UCP2 mRNA in adipose tissue and UCP3 mRNA in muscle suggest that the level of expression of the corresponding genes could account for a substantial portion of the variability of REE (however, see below). Surprisingly, these correlations are closer in populations at risk of obesity, such as Pima Indians, than in lean Caucasians.
Simoneau's presentation was the only one dealing with the UCP2 protein itself. They developed antibodies against the last 15 amino acids of human UCP2 and set up an immunometric assay using total muscle protein (10 mg). They used cytochrome oxidase (COX) to correct for mitochondrial mass and expressed their results in a relative manner, as a UCP2aCOX ratio, which basically re¯ects mitochondrial concentration of the protein but not in gravimetric amounts. Obese individuals had an increase in UCP2 and a reduction in COX, both statistically signi®cant, so that the ratio was on the average 2-fold increased in obese individuals Ð that is they are expected to have about double the mitochondrial concentration of UCP2 of lean controls. Furthermore, the UCP2aCOX ratio correlated nicely with fat mass and inversely with the RQ, but not with REE, suggesting that the increase in UCP is rather a consequence of obesity and of a tendency of obese subjects to use preferentially carbohydrates as fuel. Very low calorie diets, associated with marked weight loss, did not change UCP2 levels but reduced COX, resulting in an increased ratio and suggesting loss of mitochondria along with increased UCP2 concentration in the remaining. Surprisingly, non-obese individuals subjected to weight loss (10%), who showed the expected reduction in REE and non-REE, had an increase in UCP2 to the level of obese individuals, but without changes in COX. This observation implicates UCP2 in the oxidation of fatty acids rather than in determining REE. Regarding exercise, trained individuals showed high levels of both UCP2 and COX, and acute exercise did not change the levels of either protein.
Highly trained individuals submitted to intermittent exercise underwent an increase in COX, without changes in UCP2 following the acute exercise. Unfortunately, it is not possible as yet to come up with a unifying, inclusive hypothesis on the physiological role of these proteins. We are trying to infer the role of these proteins from manipulations of the mRNA level and just beginning to look into the protein levels. We are working, I believe, on a very risky assumption, which is that the body controls the function of these novel UCPs by regulating gene expression or the level of the protein. These proteins are most likely uncouplers of phosphorylation. If we were to engineer cells containing such proteins with the dangerous potential of sabotaging the capacity of the cells to produce their energetic currency, ATP, most of us would like to have them under tight control, particularly their activity. Being mitochondrial proteins, a system controlling protein abundance would respond slowly. Probably the protein abundance represents the potential of the cells to respond, and this may well be in¯uenced by a number of indices of energy supply and demand, but the fraction of this potential that is realized is probably regulated minute to minute. It is essential to learn what these novel UCPs actually do in the mitochondria and how their activity is regulated.
